ロード中...
Nonalcoholic Steatohepatitis and Endpoints in Clinical Trials
Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of liver disease in developed countries, and the rates of NAFLD continue to rise in conjunction with the obesity pandemic. While the majority of patients with isolated steatosis generally have a benign course, a diagnosis of nonalcoho...
保存先:
| 出版年: | Gastroenterol Hepatol (N Y) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Millennium Medical Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5193083/ https://ncbi.nlm.nih.gov/pubmed/28035202 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|